Rashad, H., Abdel monem, A., Gouda, M., Abdelaziz, T. (2024). Significance of Dicer1 in Adrenocortical Adenoma and Carcinoma (Immunohistochemical Study). Benha Medical Journal, 41(6), 30-40. doi: 10.21608/bmfj.2023.228490.1875
Heba Mohammed Rashad; Aya Abdel Aziz Abdel monem; Mohebat Helmy Gouda; Taghreed Abdelsamee Abdelaziz. "Significance of Dicer1 in Adrenocortical Adenoma and Carcinoma (Immunohistochemical Study)". Benha Medical Journal, 41, 6, 2024, 30-40. doi: 10.21608/bmfj.2023.228490.1875
Rashad, H., Abdel monem, A., Gouda, M., Abdelaziz, T. (2024). 'Significance of Dicer1 in Adrenocortical Adenoma and Carcinoma (Immunohistochemical Study)', Benha Medical Journal, 41(6), pp. 30-40. doi: 10.21608/bmfj.2023.228490.1875
Rashad, H., Abdel monem, A., Gouda, M., Abdelaziz, T. Significance of Dicer1 in Adrenocortical Adenoma and Carcinoma (Immunohistochemical Study). Benha Medical Journal, 2024; 41(6): 30-40. doi: 10.21608/bmfj.2023.228490.1875
Significance of Dicer1 in Adrenocortical Adenoma and Carcinoma (Immunohistochemical Study)
1Department of Pathology, Faculty of Medicine- Benha University, Banha University
2(M.B.B.CH)Pathology Faculty of Medicine, Banha University
3Department of pathology , Benha faculty of medicine- Kafr shoker-Egypt
4Department of pathology, faculty of medicine, benha university, benha, Egypt
Abstract
BACKGROUND: Adrenocortical tumors (ACTs) are detected in 5–7% of the general population. Dysregulation of micro-ribonucleic acid (microRNA) biogenesis machinery is involved in a variety of human cancers. Dicer1 is an essential component of microRNA machinery. AIM: To evaluate the diagnostic and prognostic significance of Dicer1 in adrenocortical adenoma (ACA) and carcinoma (ACC) and correlate the results with clinico-pathological data. Material And Methods: Forty adrenocortical lesions were included in this retrospective study included (20) ACA and (20) ACC. Clinicopathological characteristics of examined cases were correlated with the IHC expression of Dicer1. RESULTS: Dicer1 IHC expression was more frequent in ACC (65%) than in ACA (25%), (p = .04). But among ACC, a weak Dicer1 expression was significantly more frequent in advanced ACCs. There was a significant statistical inverse relation between Dicer1 expression in studied ACC cases according to tumor size, weight, Weiss score, lymph node metastasis, lympho-vascular invasion and ENSAT stage (P < .05). Other clinico-pathological variables such as age, sex, tumor site, tumor grade, and distant metastasis showed no significant statistical difference (P >.05). Dicer1 showed 76% sensitivity and 67% specificity for malignant lesions. CONCLUSION: Reduced Dicer1 expression with tumor progression in ACC may play a role in the tumorigenesis and further decline may be associated with poor prognosis in ACC.
View on SCiNiTO
Top